Anti Propionibacterium acnes activity of rhodomyrtone, an effective compound from Rhodomyrtus tomentosa (Aiton) Hassk. leaves

Anaerobe

Volumn 18, Issue 4, 2012, Pages 400-404

  Saising, Jongkon ^a   Voravuthikunchai, Supayang Piyawan ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Cytotoxicity; Propionibacterium acnes; Rhodomyrtone; Rhodomyrtus tomentosa

Indexed keywords

ALCOHOL; ANTI ACNE AGENT; ERYTHROMYCIN; HERBACEOUS AGENT; PLANT EXTRACT; PROTEINASE; RHODOMYRTONE; RHODOMYRTUS TOMENTOSA EXTRACT; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ACNE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME ACTIVITY; ENZYME SYNTHESIS; FIBROBLAST; HUMAN; HUMAN CELL; IC 50; INFLAMMATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATHOGENESIS; PLANT; PLANT LEAF; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; RHODOMYRTUS TOMENTOSA;

ANTI-BACTERIAL AGENTS; BACTERIAL LOAD; FIBROBLASTS; HUMANS; INHIBITORY CONCENTRATION 50; MICROBIAL SENSITIVITY TESTS; MYRTACEAE; PLANT EXTRACTS; PLANT LEAVES; PROPIONIBACTERIUM ACNES; TOXICITY TESTS; XANTHONES;

BACTERIA (MICROORGANISMS); PROPIONIBACTERIUM ACNES; RHODOMYRTUS TOMENTOSA;

EID: 84864330777     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2012.05.003     Document Type: Article

References (28)

1. Toyoda M., Morohashi M. Pathogenesis of acne. Med Electron Microsc 2001, 34:29-40.
2. Loveckova Y., Havlikova I. A microbiological approach to acne vulgaris. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2002, 146:29-32.
3. Burkhart C.G., Burkhart C.N., Lehmann P.F. Acne: a review of immunologic and microbiologic factors. Postgrad Med J 1999, 75:328-331.
4. Vowels B.R., Yang S., Leyden J.J. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun 1995, 63:3158-3165.
5. Purvis D., Robinson E., Merry S., Watson P. Acne, anxiety, depression and suicide in teenagers: a cross-sectional survey of New Zealand secondary school students. J Paediatr Child Health 2006, 793-796.
6. Stern R.S. Medication and medical service utilization for acne 1995-1998. J Am Acad Dermatol 2000, 43:1042-1048.
7. Tan H.H., Goh C.L., Yeo M.G., Tan M.L. Antibiotic sensitivity of Propionibacterium acnes isolates from patients with acne vulgaris in a tertiary dermatological referral centre in Singapore. Ann Acad Med Singap 2001, 30:22-25.
8. Oprica C., Emtestam L., Lapins J., Borglund E., Nyberg F., Stenlund K., et al. Antibiotic-resistant Propionibacterium acnes on the skin of patients with moderate to severe acne in Stockholm. Anaerobe 2004, 10:155-164.
9. Luk NM, Hui M, Lee HC, Fu LH, Liu Z H, Lam LY, et al. Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong. J Eur Acad Dermatol Venereol.x. doi:10.1111/j.1468-3083.2011.04351.
10. Kim C., Jung H.Y., Kim J.H., Shin C.S. Effect of monascus pigment derivatives on the electrophoretic mobility of bacteria, and the cell adsorption and antibacterial activities of pigments. Colloid Surf B 2006, 47:153-159.
11. Chomnawang M.T., Surassmo S., Nukoolkarn V.S., Gritsanapan W. Effect of Garcinia mangostana on inflammation caused by Propionibacterium acnes. Fitoterapia 2007, 78:401-408.
12. Tsai T.H., Tsai T.H., Wu W.H., Tseng J.T.P., Tsai P.J. In vitro antimicrobial and anti-inflammatory effects of herbs against Propionibacterium acnes. Food Chem 2010, 119:964-968.
13. Park J., Lee J., Jung E., Park Y., Kim K., Park B., et al. In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium sp. Eur J Pharmacol 2004, 496:189-195.
14. Cho S.C., Sultan M.Z., Moon S.S. Anti-acne activities of pulsaquinone, hydropulsaquinone, and structurally related 1, 4-quinone derivatives. Arch Pharm Res 2009, 32:489-494.
15. Saising J., Hiranrat A., Mahabusarakam W., Ongsakul M., Voravuthikunchai S.P. Rhodomyrtone from Rhodomyrtus tomentosa (Aiton) Hassk. as a natural antibiotic for staphylococcal cutaneous infections. J Health Sci 2008, 54:589-595.
16. Limsuwan S., Trip E.N., Kouwen T.R., Piersma S., Hiranrat A., Mahabusarakam W., et al. Rhodomyrtone: a new candidate as natural antibacterial drug from Rhodomyrtus tomentosa. Phytomedicine 2009, 16:645-651.
17. Voravuthikunchai S.P., Dolah S., Charernjiratrakul W. Control of Bacillus cereus in foods by Rhodomyrtus tomentosa (Ait.) Hassk. leaf extract and its purified compound. J Food Prot 2010, 73:1907-1912.
18. Clinical and Laboratory Standards Institute Performance standards for antimicrobial disk susceptibility tests, approved standard M2-A9 2006, Clinical and Laboratory Standards Institute, Wayne, PA, USA. 9th ed.
19. Clinical and Laboratory Standards Institute Methods for antimicrobial susceptibility testing of anaerobic bacteria, approved standard M11-A7 2007, Clinical and Laboratory Standards Institute, Wayne, PA, USA. 7th ed.
20. Alba V., Urban E., Angeles Dominguez M., Nagy E., Nord C.E., Palacin C., et al. In vitro activity of nadifloxacin against several Gram-positive bacteria and analysis of the possible evolution of resistance after 2 years of use in Germany. Int J Antimicrob Agents 2009, 33:272-275.
21. Akamatsu H., Tomita T., Horio T. Effects of roxithromycin on the production of lipase and neutrophil chemotactic factor by Propionibacterium acnes. Dermatology 2002, 204:277-280.
22. Holland K.T., Ingham E., Cunliffe W.J. A review, the microbiology of acne. J Appl Bacteriol 1981, 51:195-215.
23. Higaki S., Morohashi M., Yamagishi T. Anti-lipase activity of Unsei-in against Propionibacterium avidum in the human axilla. Int J Antimicrob Agents 2003, 21:597-599.
24. Lee S.E., Kim J.M., Jeong S.K., Jeon J.E., Yoon H.J., Jeong M.K., et al. Protease-activated receptor-2 mediates the expression of inflammatory cytokines, antimicrobial peptides, and matrix metalloproteinases in keratinocytes in response to Propionibacterium acnes. Arc Dermatol Res 2010, 302:745-756.
25. Oprica C., Nord C.E. European surveillance study on the antibiotic susceptibility of Propionibacterium acnes. Clin Microbiol Infect 2005, 11:204-213.
26. Gubelin W., Martinez M.A., Molina M.T., Zapata S., Valenzuela M.E. Antimicrobial susceptibility of strains of Propionibacterium acnes isolated from inflammatory acne. Rev Latinoam Microbiol 2006, 48:14-16.
27. Sianglum W, Srimanote P, Wonglumsom W, Kittiniyom K, Voravuthikunchai SP. Proteome analyses of cellular proteins in methicillin-resistant Staphylococcus aureus treated with rhodomyrtone, a novel antibiotic candidate. PLoS One;6:e16628.
28. Limsuwan S., Hesseling-Meinders A., Voravuthikunchai S.P., van Dijl J.M., Kayser O. Potential antibiotic and anti-infective effects of rhodomyrtone from Rhodomyrtus tomentosa (Aiton) Hassk. on Streptococcus pyogenes as revealed by proteomics. Phytomedicine 2011, 18:934-940.